Septal myectomy considered safe for older patients, reveals Study

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-10-18 14:30 GMT   |   Update On 2024-10-18 14:31 GMT

USA: Septal myectomy is generally safe for elderly patients with obstructive hypertrophic cardiomyopathy (HCM); however, the presence of left ventricular wall asymmetry should be regarded as a potential risk factor that could complicate outcomes. This insight comes from a recent study published in the Journal of Thoracic and Cardiovascular Surgery.

"Septal myectomy is considered safe for older patients; however, the presence of left ventricular wall asymmetry is associated with a worse prognosis," the researchers wrote.

Recent studies have highlighted the unique clinical characteristics and postoperative outcomes of elderly patients undergoing septal myectomy for obstructive hypertrophic cardiomyopathy (oHCM). Understanding how oHCM manifests in older adults is critical for improving treatment strategies and outcomes as the population ages.

Surgical septal reduction is often deferred in older adults due to concerns about elevated operative risks. Considering this, Hartzell V. Schaff, Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA, and colleagues aimed to compare the clinical and echocardiographic features of young and older patients undergoing septal myectomy for oHCM and to evaluate differences in early and late postoperative outcomes.

For this purpose, the researchers included 2,663 patients with obstructive hypertrophic cardiomyopathy who underwent transaortic septal myectomy between 2000 and 2021. These patients were categorized by age into three groups: 18-64 years, 65-74 years, and 75 years and older.

The following were the key findings of the study:

  • The median age at the time of surgery increased over the study period. Older patients had a higher prevalence of female sex, hypertension, and diabetes, while the extent of functional limitation, as measured by NYHA class, remained similar across age groups.
  • Elderly patients exhibited thinner septal and posterior walls and less pronounced asymmetry, and they were less likely to test positive for genetic markers.
  • Hospital mortality rates were 0.2%, 0.5%, and 1.3% for patients under 65, those aged 65-74, and those 75 and older, respectively.
  • Five-year survival rates were 97%, 93%, and 91%.
  • In patients over 65, the septal-to-posterior wall thickness ratio was significantly associated with increased mortality, whereas this correlation was not observed in younger patients.
  • Most patients reported an improvement in quality of life following myectomy.

The findings revealed that the clinical characteristics of obstructive hypertrophic cardiomyopathy (oHCM) in older patients differ from those in younger individuals. The researchers observed that older patients exhibit more symmetric but less extensive ventricular hypertrophy and lower rates of positive genetic testing. This indicates that HCM may have distinct clinical and morphological variants in the elderly.

"While septal myectomy is considered safe for older patients, the presence of left ventricular wall asymmetry is associated with a poorer prognosis," they concluded.

Reference:

DOI: https://www.jtcvs.org/article/S0022-5223(24)00904-8/abstract


Tags:    
Article Source : Journal of Thoracic and Cardiovascular Surgery

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News